The neglected tropical disease treatment market is projected to grow from USD 3.9 billion in 2025 to USD 5.9 billion by 2035, at a CAGR of 4.3%. Anti-Parasite will dominate with a 44.9% market share, while leishmaniasis will lead the disease type segment with a 28.6% share.